CellAegis Devices

139 Mulock Ave, 1st Floor
Toronto, Ontario M6N 1G9 CANADA
Click for website

Research Sector Medical Devices

Summary Description Automated noninvasive devices that are shown to reduce damage to organs during surgery or trauma.

Management Rocky Ganske, CEO; John Berton, Chairman; Vera Belaoussoff, VP of Corporate Development

Click here for Financial Data
Keywords: Cardiology, Surgery, Renal, Womens Health, Urology, Gastroenterology, Pulmonology, metabolic, organ, myocardial, stroke, tram, transplantation,


Updated: Apr. 06, 2016


CellAegis Deices is the developer of the automated, noninvasive autoRICTM Device to enable Remote Ischemic Conditioning, with applications in acute and chronic care settings. By activating innate mec......view more

Products / Services

The autoRI Device provides a non-invasive, safe and accurate device to automate RIC. Placed around the arm, CellAegis autoRIC Device for the first time allows simple, consistent, reliable and cost eff......view more

Technology / Differentiation

Remote Ischemic Conditioning (RIC) activates innate mechanisms of metabolic protection and has the potential to revolutionize the treatment of ischemic-related reperfusion injury. In cardiovascular ca...view more

Market / Customers

Cath Lab, EMS, Hospitals, Recovery facilities, at home, or in public work settings alongside an AED.......view more

Revenue / Funding

Funding to Date: ~$17M 12/2013 Financing Sought: ~$10M - $15M 12/2013...view more


The autoRI Device is the only patented device with CE Mark certification in Europe that can automate the process of RIC. The autoRI Device is for research only and not for sale in the US and Canada....view more


Gowling Lafleur Henderson LLP...view more